McNaughton Thomas 4
4 · Biostage, Inc. · Filed Jun 18, 2019
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
McNaughton Thomas
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2019-06-14+35,000→ 35,000 totalExercise: $2.55From: 2019-06-14Exp: 2022-06-14→ Common Stock, par value $0.01 per share (35,000 underlying)